Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma

por Diem, S, Kasenda, B, Spain, L, Martin-Liberal, J, Marconcini, R, Gore, M, Larkin, J
Publicado 2016

Targeting immunoliposomes to EGFR-positive glioblastoma

por Kasenda, B., König, D., Manni, M., Ritschard, R., Duthaler, U., Bartoszek, E., Bärenwaldt, A., Deuster, S., Hutter, G., Cordier, D., Mariani, L., Hench, J., Frank, S., Krähenbühl, S., Zippelius, A., Rochlitz, C., Mamot, C., Wicki, A., Läubli, H.
Publicado 2022

High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)

por Fritsch, K, Kasenda, B, Schorb, E, Hau, P, Bloehdorn, J, Möhle, R, Löw, S, Binder, M, Atta, J, Keller, U, Wolf, H-H, Krause, S W, Heß, G, Naumann, R, Sasse, S, Hirt, C, Lamprecht, M, Martens, U, Morgner, A, Panse, J, Frickhofen, N, Röth, A, Hader, C, Deckert, M, Fricker, H, Ihorst, G, Finke, J, Illerhaus, G
Publicado 2017